Provided by Tiger Trade Technology Pte. Ltd.

Global X Genomics & Biotechnology ETF

63.57
+1.352.17%
Post-market: 63.40-0.1689-0.27%16:29 EDT
Volume:11.26K
Turnover:710.03K
Market Cap:95.65M
PE:- -
High:63.76
Open:62.31
Low:62.22
Close:62.22
52wk High:68.00
52wk Low:36.13
Shares:1.50M
Float Shares:1.50M
Volume Ratio:0.23
T/O Rate:0.75%
Dividend:0.65
Dividend Rate:1.02%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Guardant Health CIO Kumud Kalia Disposes of 4,000 Common Shares Worth $632,193.20

Reuters
·
50 mins ago

Moderna CFO James M. Mock Disposes of 34,836 Common Shares Worth $4.68 Million

Reuters
·
2 hours ago

Guardant Health, - Evicore by Evernorth to Cover Shield Blood Test for Crc Screening Effective Jan 1, 2027

THOMSON REUTERS
·
2 hours ago

Natera Executive Chairman Matthew Rabinowitz Disposes of USD 16.32 Million in Common Shares

Reuters
·
Sep 12

Moderna Inc. Stock Rallies 5.4%, Outperforms Peers

Dow Jones
·
Sep 12

IntegraGen receives rival takeover bids amid court‑ordered restructuring

TIPRANKS
·
Sep 12

Moderna Inc Stock (MRNA) Moved Up by 8.63% on Sep 11: A Full Analysis

TradingKey
·
Sep 12

Moderately bullish activity in Moderna with shares up 8.03%

TIPRANKS
·
Sep 12

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Sep 12

Berenberg Boosts Price Target on Moderna to $100 From $45, Keeps Hold Rating

MT Newswires Live
·
Sep 11

Analysts Conflicted on These Healthcare Names: Moderna (MRNA), Merck & Company (MRK) and Pacific Biosciences (PACB)

TIPRANKS
·
Sep 11

Analysts Offer Insights on NA Companies: Expeditors International (EXPD) and Illumina (ILMN)

TIPRANKS
·
Sep 11

Twist Bioscience Price Target Announced at $45.00/Share by BWS Financial

Dow Jones
·
Sep 10

Moderna Set for 3 Near-Term INT Data Readouts, UBS Says

MT Newswires Live
·
Sep 09

UBS Adjusts Guardant Health Price Target to $225 From $175, Maintains Buy Rating

MT Newswires Live
·
Sep 09

Twist Bioscience initiated with a Sell at BWS Financial

TIPRANKS
·
Sep 09

UBS Initiates Coverage on Twist Bioscience With Neutral Rating, $144 Price Target

MT Newswires Live
·
Sep 09

Twist Bioscience CEO, CFO to Speak at Baird Global Healthcare Conference Fireside Chat

Reuters
·
Sep 09

Structure weakness ‘disconnected’ from underlying data, says Jefferies

TIPRANKS
·
Sep 09

Moderately bullish activity in Moderna with shares down 1.79%

TIPRANKS
·
Sep 09